Cargando…
Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease
BACKGROUND: Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. METHODS: To address the discrepancy, we measured the activity and density of SERT in the neocortex of 3–2...
Autores principales: | Metaxas, Athanasios, Anzalone, Marco, Vaitheeswaran, Ramanan, Petersen, Sussanne, Landau, Anne M., Finsen, Bente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495598/ https://www.ncbi.nlm.nih.gov/pubmed/31043179 http://dx.doi.org/10.1186/s13195-019-0491-2 |
Ejemplares similares
-
Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer’s disease
por: Metaxas, Athanasios, et al.
Publicado: (2019) -
Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice
por: von Linstow, Christian Ulrich, et al.
Publicado: (2017) -
Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022) -
Tumor Necrosis Factor (TNF) Is Required for Spatial Learning and Memory in Male Mice under Physiological, but Not Immune-Challenged Conditions
por: Mygind, Leda, et al.
Publicado: (2021) -
Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients
por: Metaxas, Athanasios, et al.
Publicado: (2019)